Literature DB >> 9599967

The allopurinol hypersensitivity syndrome.

H J Pluim1, M van Deuren, J F Wetzels.   

Abstract

We describe a 61-year-old male patient who was treated with allopurinol and developed fever, a skin rash, eosinophilia and severe renal and liver dysfunction. We discuss the allopurinol hypersensitivity syndrome as a serious complication of the use of allopurinol, and briefly review the aetiology, prevention and treatment modalities.

Entities:  

Mesh：

Substances：

Year:  1998        PMID： 9599967     DOI： 10.1016/s0300-2977(97)00088-0

Source DB:  PubMed          Journal:  Neth J Med        ISSN： 0300-2977            Impact factor:   1.422


  9 in total

1.  [Allopurinol-induced hypersensitivity syndrome resulting in death].

Authors:  Sören Laurisch; Maren Jaedtke; Reyhan Demir; Sajoscha A Sorrentino; Jan T Kielstein; Hans-Oliver Rennekampff; Peter M Vogt; Gerd P Meyer; Martin Fuchs; Gunnar Klein; Hartmut Drexler; Bernhard Schieffer; L Christian Napp
Journal:  Med Klin (Munich)       Date:  2010-04

Review 2.  Rheumatologic disease with peripheral eosinophilia.

Authors:  Nüket Bavbek; Ayşe Kargili; Handan Cipil; Ali Koşar; Yaşar Karaaslan
Journal:  Rheumatol Int       Date:  2004-04-20       Impact factor: 2.631

3.  Crystal arthritis: Is HLAB genotyping the future of gout pharmacogenomics?

Authors:  Jasvinder A Singh
Journal:  Nat Rev Rheumatol       Date:  2013-02-12       Impact factor: 20.543

Review 4.  Eosinophilia in rheumatologic diseases: a prospective study of 1000 cases.

Authors:  Ayşe Kargili; Nüket Bavbek; Arif Kaya; Ali Koşar; Yaşar Karaaslan
Journal:  Rheumatol Int       Date:  2004-04-06       Impact factor: 2.631

5.  An effective strategy to prevent allopurinol-induced hypersensitivity by HLA typing.

Authors:  Jae-Woo Jung; Dong-Ki Kim; Heung-Woo Park; Kook-Hwan Oh; Kwon-Wook Joo; Yon-Su Kim; Curie Ahn; Kyung Wha Lee; Sang-Heon Cho; Kyung-Up Min; Hye-Ryun Kang
Journal:  Genet Med       Date:  2015-01-29       Impact factor: 8.822

6.  Pharmacokinetics, pharmacodynamics, and tolerability of LC350189, a novel xanthine oxidase inhibitor, in healthy subjects.

Authors:  Seonghae Yoon; Donghoon Shin; Howard Lee; In-Jin Jang; Kyung-Sang Yu
Journal:  Drug Des Devel Ther       Date:  2015-08-31       Impact factor: 4.162

7.  Allopurinol reduces antigen-specific and polyclonal activation of human T cells.

Authors:  Damián Pérez-Mazliah; María C Albareda; María G Alvarez; Bruno Lococo; Graciela L Bertocchi; Marcos Petti; Rodolfo J Viotti; Susana A Laucella
Journal:  Front Immunol       Date:  2012-09-21       Impact factor: 7.561

Review 8.  Allopurinol hypersensitivity: a systematic review of all published cases, 1950-2012.

Authors:  Sheena N Ramasamy; Cameron S Korb-Wells; Diluk R W Kannangara; Myles W H Smith; Nan Wang; Darren M Roberts; Garry G Graham; Kenneth M Williams; Richard O Day
Journal:  Drug Saf       Date:  2013-10       Impact factor: 5.228

9.  HLA Allele Frequencies in 5802 Koreans: Varied Allele Types Associated with SJS/TEN According to Culprit Drugs.

Authors:  Hye Jung Park; Young Joo Kim; Dong Hyun Kim; Junho Kim; Kyung Hee Park; Jung Won Park; Jae Hyun Lee
Journal:  Yonsei Med J       Date:  2016-01       Impact factor: 2.759
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.